Search - tctmd.com

Displaying 1 - 20 of 72

Sort: Relevancy | Date

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

DAPT’s Role After CABG Questioned: TACSI and TOP-CABG

News Conference News ESC 2025

DAPT’s Role After CABG Questioned: TACSI and TOP-CABG

September 05, 2025

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

News Conference News ESC 2025

NEWTON-CABG CardioLink-5: Evolocumab Doesn’t Prevent SVG Failure

Michael O'Riordan

September 04, 2025

EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes

News Conference News ACC 2025

EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes

April 07, 2025

Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis

News Conference News STS 2025

Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis

Yael L. Maxwell

February 05, 2025

Transplant Recipients on Medicaid More Likely to Develop Allograft Vasculopathy

News Conference News STS 2025

Transplant Recipients on Medicaid More Likely to Develop Allograft Vasculopathy

Yael L. Maxwell

January 30, 2025

STS Experts Tackle Need For Women-Only Trials in Surgery

News Conference News STS 2025

STS Experts Tackle Need For Women-Only Trials in Surgery

Yael L. Maxwell

January 29, 2025

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

News Conference News STS 2025

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Yael L. Maxwell

January 27, 2025

‘Teleprehabilitation’ Before Cardiac Surgery Improves the Outcomes That Follow

News Conference News EACTS 2024

‘Teleprehabilitation’ Before Cardiac Surgery Improves the Outcomes That Follow

Yael L. Maxwell

October 17, 2024

Enhanced Recovery After Cardiac Surgery: Fewer Complications, Shorter Stays

News Conference News EACTS 2024

Enhanced Recovery After Cardiac Surgery: Fewer Complications, Shorter Stays

Yael L. Maxwell

October 16, 2024

In-Hospital Mortality Higher When Female CABG Patients Have Male Surgeons

News Conference News EACTS 2024

In-Hospital Mortality Higher When Female CABG Patients Have Male Surgeons

Yael L. Maxwell

October 14, 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

News Conference News EACTS 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

Yael L. Maxwell

October 11, 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

News Conference News HRS 2024

CASA-AF: Similar 3-Year Efficacy for Surgical and Catheter Ablation

May 23, 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

Concomitant AF Procedures During Non-Mitral Surgery Less Likely in Women

News Conference News

Concomitant AF Procedures During Non-Mitral Surgery Less Likely in Women

Yael L. Maxwell

May 09, 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

News Conference News STS 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

Yael L. Maxwell

February 09, 2024

Where You Live Matters More Than Hospital Volume for Heart Transplant Outcomes

News Conference News STS 2024

Where You Live Matters More Than Hospital Volume for Heart Transplant Outcomes

Yael L. Maxwell

February 06, 2024

Multiarterial Grafting in CABG Triumphs Again in Large Database Study

News Conference News STS 2024

Multiarterial Grafting in CABG Triumphs Again in Large Database Study

Yael L. Maxwell

January 29, 2024

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.